JFNIX
Price
$66.37
Change
+$0.63 (+0.96%)
Updated
Jun 6 closing price
Net Assets
4.66B
LHCOX
Price
$18.52
Change
+$0.04 (+0.22%)
Updated
Jun 6 closing price
Net Assets
7.33M
Interact to see
Advertisement

JFNIX vs LHCOX

Header iconJFNIX vs LHCOX Comparison
Open Charts JFNIX vs LHCOXBanner chart's image
Janus Henderson Global Life Sciences I
Price$66.37
Change+$0.63 (+0.96%)
VolumeN/A
Net Assets4.66B
Lord Abbett Health Care F3
Price$18.52
Change+$0.04 (+0.22%)
VolumeN/A
Net Assets7.33M
JFNIX vs LHCOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JFNIX vs. LHCOX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JFNIX is a Buy and LHCOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JFNIX has more cash in the bank: 4.66B vs. LHCOX (7.33M). LHCOX pays higher dividends than JFNIX: LHCOX (0.61) vs JFNIX (0.42). JFNIX was incepted earlier than LHCOX: JFNIX (16 years) vs LHCOX (6 years). LHCOX (2.99) is less costly to investors than JFNIX (0.77). LHCOX is a more actively managed with annual turnover of: 88.00 vs. JFNIX (35.00). LHCOX has a lower initial minimum investment than JFNIX: LHCOX (0) vs JFNIX (2500). LHCOX annual gain was more profitable for investors over the last year : -5.26 vs. JFNIX (-13.08). JFNIX return over 5 years is better than : 8.38 vs. LHCOX (7.64).
JFNIXLHCOXJFNIX / LHCOX
Total Expense Ratio0.770.68113%
Annual Report Gross Expense Ratio0.772.9926%
Fund Existence16 years6 years-
Gain YTD-3.352-4.84069%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.66B7.33M63,472%
Annual Yield % from dividends0.420.6169%
Returns for 1 year-13.08-5.26249%
Returns for 3 years8.799.7490%
Returns for 5 years8.387.64110%
Returns for 10 years12.44N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDNRX71.38N/A
N/A
Janus Henderson Growth And Income R
PGRUX9.56N/A
N/A
Principal Global Real Estate Sec R5
TEMUX14.87N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
SCIUX11.18N/A
N/A
Invesco Income Advantage U.S. Fund R5
GEBRX10.73N/A
N/A
Goldman Sachs ESG Em Mkts Eq R